Cardiovascular Drugs and Therapy

, Volume 25, Issue 6, pp 561–570

Stroke Prevention in Atrial Fibrillation

Authors

  • Jonathan P. Piccini
    • Division of Cardiology, Duke Clinical Research InstituteDuke University School of Medicine
  • Thomas W. Wallace
    • Heart Clinic Arkansas
  • Manesh R. Patel
    • Division of Cardiology, Duke Clinical Research InstituteDuke University School of Medicine
    • Division of Cardiology, Duke Clinical Research InstituteDuke University School of Medicine
    • Cardiovascular Thrombosis CenterDuke Clinical Research Institute
Article

DOI: 10.1007/s10557-011-6334-4

Cite this article as:
Piccini, J.P., Wallace, T.W., Patel, M.R. et al. Cardiovasc Drugs Ther (2011) 25: 561. doi:10.1007/s10557-011-6334-4

Key words

Atrial fibrillationStrokeAnticoagulantsVitamin K antagonistsDirect thrombin inhibitorsFactor Xa inhibitorsBleedingRisk stratification

Copyright information

© Springer Science+Business Media, LLC 2011